NasdaqGM - Nasdaq Real Time Price USD

Aimei Health Technology Co., Ltd (AFJK)

Compare
10.75
0.00
(0.00%)
At close: January 21 at 4:00:00 PM EST

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Junheng Xie CEO, Secretary & Director -- -- 1989
Mr. Heung Ming Wong CFO & Director -- -- 1970

Aimei Health Technology Co., Ltd

10 East 53rd Street
Suite 3001
New York, NY 10022
United States
212 845 9945
Industry: 
Shell Companies

Description

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Corporate Governance

Aimei Health Technology Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

January 21, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

January 14, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 10, 2025 at 12:00 AM UTC

PRE 14A: Proxy Statements

December 31, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 3, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

November 21, 2024 at 12:00 AM UTC

PRE 14A: Proxy Statements

November 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 9, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

June 20, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters